Detalhe da pesquisa
1.
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
Eur Respir J
; 59(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561291
2.
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.
J Allergy Clin Immunol
; 127(2): 509-516.e1-5, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21281875
3.
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Lancet Respir Med
; 9(1): 57-68, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32916135
4.
Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression.
J Immunol
; 178(7): 4658-66, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17372025
5.
Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.
Immunology
; 105(1): 56-62, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11849315
6.
Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.
J Immunol
; 172(5): 3252-9, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14978133